Loading...
Loading...
Loading...

We are the Peptide Experts


JPT Peptide Technologies is the leading manufacturer of custom peptides and innovative peptide-based products for research and clinical applications. For more than 15 years we have been serving the global biomedical community with products and services based on science and quality.

Located in our state-of-the-art laboratories in Berlin, Germany, JPT operates according to the latest ISO 9001:2015 regulations.


Custom Peptide Synthesis


Our Quality Guarantee

Since 2004, JPT has maintained an active quality management system that is reviewed, audited and certified annually by an independent certification body (TÜV Rheinland) to ISO 9001 standards. This includes full process documentation and an early warning system in case of problems.



Product Finder

Filter by

Research Fields

Cell Therapy & Vaccines

Cell Therapy & Vaccines

JPT offers a large portfolio of peptide products and services supporting all development phases of new cell therapies and vaccines. These products range from discovery tools for epitope and target identification, to various peptide formats for immune monitoring and clinical grade peptides to support clinical vaccination and cell therapy trials.  Learn more
Immunology

Immunology

JPT has developed a variety of unique peptide-based products allowing systematic evaluation of cellular and humoral immunity. In addition to peptide formats allowing T-cell and B-cell epitope discovery, antigen-specific T-cell stimulation and immune monitoring our clinical grade products support clinical trials for the development of new immunotherapeutics and vaccines. Learn more
Neo-Epitope Discovery & Therapy

Neo-Epitope Discovery & Therapy

Neo-epitopes are important targets for individualized cancer immunotherapy. JPT’s high-throughput peptide techniques enable access to customized peptide products for neo-epitope prioritization and validation, individualized therapy development and immune monitoring. Learn more
Proteomics

Proteomics

Proteomics is the study of a cell's protein inventory at different times by protein identification and quantification. The application of mass spectrometry and more specifically LC-MS/MS has tremendously facilitated this process. JPT developed proprietary approaches for the provision of quantified custom peptides and ready-to-use products enabling protein biomarker identification and quantitation. Learn more
COVID-19

COVID-19

JPT was the first company responding to the Covid-19 pandemic with the launch of a broad SARS CoV-2 genome spanning portfolio of peptide tools. The ready to use and custom peptide tools include antigen spanning PepMixTM peptide pools and PepStarTM peptide microarrays of SARS-CoV-2 wild type and mutated antigen sequences as well as antigens from other relevant corona viruses.  Learn more
Loading...

News

End-of-Year Offer: 20% Discount on Custom Peptides

As 2023 draws to a close and winter festivities are underway, we at JPT are slowly preparing for the coming year. As the provider of the largest variety of custom peptide formats, it is our pleasure to offer you an End-of-Year Special: From now until December 31st go ahead and take advantage of a 20% discount...

December 2023

Peptide Tools to Study Tropical Diseases: Explore our latest PepMixes!

JPT’s PepMix peptide pools cover many common applications, from antigen-specific stimulation in T cell assays for immune monitoring to vaccine development. We strive to keep up-to-date with emerging pathogens or spreading variants, such as Nipah virus or various Flaviviridae...

November 2023

NEW PepMix Peptide Pools for the highly mutated SARS2 variant Pirola (BA.2.86)

We provide researchers with up-to-date PepMix Peptide Pools for immune monitoring and immune response profiling that cover the SARS-CoV-2 virus’ spike glycoprotein and respective RBD...

November 2023

Check our list of products, click and go.

Get a quote